O

OrbiMed Portfolio holdings

AUM $4.17B
1-Year Est. Return 30.9%
This Quarter Est. Return
1 Year Est. Return
+30.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.82B
AUM Growth
-$649M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
132
New
Increased
Reduced
Closed

Top Buys

1
+$93.6M
2
+$86.8M
3
+$84.8M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$38.9M
5
CYTK icon
Cytokinetics
CYTK
+$38.4M

Top Sells

1
+$81.3M
2
+$55.2M
3
+$48.4M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$47.5M
5
EVH icon
Evolent Health
EVH
+$47.1M

Sector Composition

1 Healthcare 98.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
$1.31M 0.03%
1,787,767
102
$1.29M 0.03%
192,700
103
$1.23M 0.03%
+32,400
104
$1.06M 0.02%
+250,000
105
$880K 0.02%
95,100
106
$877K 0.02%
+26,700
107
$530K 0.01%
941,275
108
$509K 0.01%
1,149,300
-579,000
109
$486K 0.01%
+140,428
110
$273K 0.01%
80,420
111
– –
-252,300
112
– –
-379,130
113
– –
-1,270,400
114
– –
-103,000
115
– –
-2,161,185
116
– –
-764,600
117
– –
-106,200
118
– –
-1,665,115
119
– –
-123,900
120
– –
-11,024,000
121
– –
0
122
– –
-351,618
123
– –
-387,000
124
– –
0
125
– –
-1,449,073
2 3 4
5
6